Gonadorelin Dosage Guide
Complete guide to Gonadorelin dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose per Injection
100 mcg – 200 mcg
Frequency
2 times per day
Total Daily Dose
200 mcg – 400 mcg
Route
subcutaneous
Cycle Length
8–12 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Men
100-200mcg subcutaneously 2-3 times daily.
Women (fertility)
Per clinical protocol.
HRT support
Often combined with other therapies.
Administration Method
Subcutaneous injection. Pulsatile administration mimics natural GnRH release patterns. Often used during or after testosterone therapy.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.04 ml
Syringe units (U-100): 4.0 units
Pre-filled with Gonadorelin defaults. Adjust values as needed.
Side Effects to Monitor
Headache, flushing, injection site reactions. In women may cause ovarian hyperstimulation. Generally well-tolerated.
Safety Considerations & Risks
Continuous (non-pulsatile) administration can actually suppress hormone production. Requires proper protocol design.